Related Experiment Video
Updated: Apr 3, 2026

06:52
Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
Published on: July 22, 2020
7.1K
An Evolutionary Approach for Identifying Driver Mutations in Colorectal Cancer
Jasmine Foo1, Lin L Liu2, Kevin Leder3
1Department of Mathematics, University of Minnesota Twin Cities, St. Paul, Minnesota, United States of America.
Plos Computational Biology
|September 18, 2015
Summary
Identifying cancer-driving mutations is key for targeted therapies. A new Hitchhiking Index helps distinguish driver from passenger mutations using population dynamics models, aiding drug discovery.
Area of Science:
- Genomics
- Cancer Biology
- Computational Biology
Background:
- Cancer is traditionally viewed as a genetic disease, driving extensive whole-genome sequencing efforts.
- Identifying driver mutations that confer a cellular fitness advantage is crucial for effective cancer treatment and drug development.
- Distinguishing driver mutations from passenger mutations is a significant challenge in cancer genomics.
Purpose of the Study:
- To develop a novel statistical index, the Hitchhiking Index, for differentiating driver from passenger mutations.
- To apply this index to colorectal cancer mutation data to prioritize candidate mutations for validation.
- To aid in the drug discovery process by identifying functionally relevant mutations.
Main Methods:
- Development of a novel statistical index, the Hitchhiking Index.
- Application of a population dynamics model for mutation accumulation and selection.
- Analysis of a colorectal cancer mutational dataset.
Main Results:
- The Hitchhiking Index was designed to assess the probability of a gene being a passenger alteration.
- The methodology was successfully applied to a colorectal cancer mutational dataset.
- The index aids in prioritizing candidate mutations for functional validation.
Conclusions:
- The Hitchhiking Index provides a novel statistical approach to distinguish driver from passenger mutations.
- This method aids in prioritizing mutations for functional validation in cancer research.
- The approach contributes to advancing cancer drug discovery by focusing on critical mutations.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
15.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.5K
Tumor Progression
7.9K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.9K

